抑制剂简介
抑制剂是一类能够降低或阻止生物体内的酶活性、受体的活性或是细胞内特定反应过程的小分子化合物。它们在有机化学、化学化工和生物医药领域中有着广泛的应用,尤其是在药物研发方面。
分类与作用机制
应用领域
总结
抑制剂的研究和发展对于理解生命过程至关重要,并在药物开发、基础科学研究等多个领域发挥着重要作用。随着技术的进步,新的抑制剂不断被发现和开发出来,为医学治疗提供了更多的可能性。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
5-[2-(叔丁基)-4-(4-氟苯基)-1H-咪唑-5-基]-3-(2,2-二甲基丙基)-3H-咪唑并[4,5-B]吡啶-2-胺甲磺酸盐 | Ralimetinib Mesylate | 862507-23-1 | C26H37FN6O6S2 |
|
5-[2,4-二羟基-6-(4-硝基苯氧基)苯基]-N-(1-甲基-4-哌啶基)-3-异恶唑甲酰胺 | NMS-E973 | 1253584-84-7 | C22H22N4O7 |
|
5-[2,4-二羟基-5-异丙基苯基]-N-乙基-4-[4-(4-吗啉基甲基)苯基]-3-异恶唑甲酰胺 | 5-(2,4-dihydroxy-5-isopropylphenyl)-4-(4-morpholin-4-ylmethylphenyl)isoxazole-3-carboxylic acid ethylamide | 747412-49-3 | C26H31N3O5 |
|
5-[(二甲氨基)磺酰基]-N-(5-甲基-2-噻唑基)-2-(1-吡咯烷基)苯甲酰胺 | 5-(dimethylsulfamoyl)-N-(5-methyl-1,3-thiazol-2-yl)-2-(pyrrolidin-1-yl)benzamide | 790702-57-7 | C17H22N4O3S2 |
|
5-[(2-环丙基-7,8-二甲氧基-2H-色烯-5-基)甲基]嘧啶-2,4-二胺 | iclaprim | 192314-93-5 | C19H22N4O3 |
|
5-[(2,2-二氟-1,3-苯并二恶茂-5-基)亚甲基]噻唑烷-2,4-二酮 | 5-[(2,2-Difluoro-1,3-benzodioxol-5-yl)methylidene]thiazolidine-2,4-dione | 648449-76-7 | C11H5F2NO4S |
|
5-[(1,2-二氢-2-氧代-3H-吲哚-3-基)甲基]-2,4-二甲基-1H-吡咯-3-丙酸 | 5-[(1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-propanoic acid | 252916-29-3 | C18H18N2O3 |
|
5-(N-乙基-N-异丙基)阿米洛利 | ethyl isopropyl amiloride | 1154-25-2 | C11H18ClN7O |
|
5-(6-喹喔啉亚甲基)-2,4-噻唑啉二酮 | 5-(6-Quinoxalinylmethylene)-2,4-thiazolidinedione | 648450-29-7 | C12H7N3O2S |
|
5-(5-氯-2,4-二羟基苯基)-N-乙基-4-(4-甲氧基苯基)异噁唑-3-羧酰胺 | VER 50589 | 747413-08-7 | C19H17ClN2O5 |
|
5-(4-甲氧基苯基)-1-(4-氨基磺酰基苯基)-3-苯基-2-吡唑啉 | ML141 | 71203-35-5 | C22H21N3O3S |
|
5-(4-氯苯基)-N-(3,5-二甲氧基苯基)-2-呋喃甲酰胺 | [3H]-A-803467 | 944261-79-4 | C19H16ClNO4 |
|
5-(4-氟苯基)-2-脲基噻吩-3-甲酰胺 | 2-(carbamoylamino)-5-(4-fluorophenyl)thiophene-3-carboxamide | 507475-17-4 | C12H10FN3O2S |
|
5-(4-乙基苯亚甲基)绕丹宁(该产品不可在美国销售) | 10058-F4 | 403811-55-2 | C12H11NOS2 |
|
5-(3-苄氧基苯基)-7-[反式-3-[(吡咯烷-1-基)甲基]环丁基]-7H-吡咯并[2,3-D]嘧啶-4-胺 | NVP-ADW742 | 475488-23-4 | C28H31N5O |
|
5-(3-溴苯基)-1,3-二氢-2H-苯并呋喃[3,2-e]-1,4-二氮杂-2--2- | 5-BDBD | 768404-03-1 | C17H11BrN2O2 |
|
5-(2-氨基-8-氟[1,2,4]三唑并[1,5-A]吡啶-6-基)-N-(叔丁基)-3-吡啶磺酰胺 | CZC24832 | 1159824-67-5 | C15H17FN6O2S |
|
5-(2-氧代-2-苯基乙氧基)-1(2H)-异喹啉酮 | 5-(2-Oxo-2-phenylethoxy)isoquinolin-1(2H)-one | 1048371-03-4 | C17H13NO3 |
|
5-(2-氟-4-吡啶基)-2-(苯基甲氧基)-N-3-吡啶基苯甲酰胺 | GSK-2578215A | 1285515-21-0 | C24H18FN3O2 |
|
5-(2,6-二氯苯基)-2-((2,4-二氟苯基)硫基)-6H-嘧啶并[1,6-b]哒嗪-6-酮 | VX-745 | 209410-46-8 | C19H9Cl2F2N3OS |
|
5-(1H-吲哚-3-基甲基)-3-甲基-2-硫酮-4-咪唑烷酮 | necrostatin-1 | 4311-88-0 | C13H13N3OS |
|
5,6-二氢-6-甲基-4H-1,3-噻嗪-2-胺 | 2-amino-5,6-dihydro-6-methyl-4H-1,3-thiazine | 1121-91-1 | C5H10N2S |
|
5,5'-(2,5-呋喃二基)二-2-噻吩甲醇 | RITA | 213261-59-7 | C14H12O3S2 |
|
5,11-二氢-2-[[2-甲氧基-4-[[4-(4-甲基-1-哌嗪基)-1-哌啶基]羰基]苯基]氨基]-5,11-二甲基-6H-嘧啶并[4,5-B][1,4]苯并二氮杂卓-6-酮 | Lrrk2-IN-1 | 1234480-84-2 | C31H38N8O3 |
|
5'-{[(2Z)-4-氨基丁-2-烯-1-基](甲基)氨基}-5'-脱氧腺苷 | 5'-<<(Z)-4-Amino-2-butenyl>methylamino>-5'-deoxyadenosine | 123642-27-3 | C15H23N7O3 |
|
42-(二甲基亚膦酰)雷帕霉素 | Ridaforolimus | 572924-54-0 | C53H84NO14P |
|
4-辛基酚乙氧基化物 | 2-(2-chloro-4-iodophenylamino)-N-(cyclopropylmethoxy)-3,4-difluorobenzamide | 212631-79-3 | C17H14ClF2IN2O2 |
|
4-苯基丁酸钠盐 | Benzenebutyric acid (sodium) | 1716-12-7 | C10H12NaO2 |
|
4-苄基-2-甲基-1,2,4-噻二唑烷-3,5-二酮 | 4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione | 327036-89-5 | C10H10N2O2S |
|
4-苄基-2-(萘-1-基)-[1,2,4]噻二唑烷-3,5-二酮 | Tideglusib | 865854-05-3 | C19H14N2O2S |
|
4-脱氧尿苷 | Zebularine | 3690-10-6 | C9H12N2O5 |
|
4-羟基-3,3-二甲基-2H-苯并[g]吲哚-2,5(3H)-二酮 | BVT948 | 39674-97-0 | C14H11NO3 |
|
4-羟基-2,6-二甲基苯甲腈 | pictilisib | 957054-30-7 | C23H27N7O3S2 |
|
4-甲基-N1-(3-苯基丙基)-1,2-苯二胺 | 4-Methyl-N1-(3-phenylpropyl)benzene-1,2-diamine | 749886-87-1 | C16H20N2 |
|
4-甲基-N-[4-[(4-甲基-1-哌嗪基)甲基]-3-(三氟甲基)苯基]-3-[2-(1H-吡唑并[3,4-b]吡啶-5-基)乙炔基]苯甲酰胺 | GZD824 | 1257628-77-5 | C29H27F3N6O |
|
4-氯-N-[2-[[5-(三氟甲基)-2-吡啶基]磺酰基]乙基]-苯甲酰胺 | GSK3787 | 188591-46-0 | C15H12ClF3N2O3S |
|
4-氨基-[2,3']联噻吩-5-甲酰胺 | SC 514 | 354812-17-2 | C9H8N2OS2 |
|
4-氨基-N-(3-氯-4-氟苯基)-N'-羟基-1,2,5-恶二唑-3-甲脒 | 4-amino-N-(3-chloro-4-fluorophenyl)-N'-hydroxy-1,2,5-oxadiazole-3-carboximidamide | 914471-09-3 | C9H7ClFN5O2 |
|
4-氨基-5-氯-2-乙氧基-N-[[4-(4-氟苄基)-2-吗啉基]甲基]苯甲酰胺枸橼酸盐 | mosapride citrate | 112885-42-4 | C6H8O7*C21H25ClFN3O3 |
|
4-氟-N-[2-[4-(7-甲氧基-1-萘)-1-哌嗪基]乙基]-苯胺 | S 14506 | 135722-25-7 | C24H26FN3O2 |
|
4-吡啶羧酸 2-苯基酰肼 | 4-pyridinecarboxylic acid 2-phenylhydrazide | 91396-88-2 | C12H11N3O |
|
4-叔丁基苯乙腈 | 4-tert-butylbenzyl cyanide | 3288-99-1 | C12H15N |
|
4-二氟苯基)苯甲酰胺 | 4-butoxy-N-(2,4-difluorophenyl)benzamide | 433967-28-3 | C17H17F2NO2 |
|
4-乙酰氨基-N-(2'-氨基苯基)-苯甲酰胺 | CI-994 | 112522-64-2 | C15H15N3O2 |
|
4-[[((2,3-Dihydro-1,1,3,3-tetramethyl-2-oxo-1H-inden-5-yl)羰基]氨基]苯甲酸 | 4-[(1,1,3,3-Tetramethyl-2-oxoindene-5-carbonyl)amino]benzoic acid | 215307-86-1 | C21H21NO4 |
|
4-[[[(4-氟苯基)氨基]羰基]氨基]苯磺酰胺 | SLC-0111 | 178606-66-1 | C13H12FN3O3S |
|
4-[[[(1R,2S,5R)-7-氧代-6-(苯基甲氧基)-1,6-二氮杂双环[3.2.1]辛烷-2-基]羰基]氨基]-1-哌啶羧酸叔丁酯 | tert-butyl 4-((2S,5R)-6-(benzyloxy)-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboxamido)piperidine-1-carboxylate | 1174020-63-3 | C24H34N4O5 |
|
4-[[[(1R,2S,5R)-6-羟基-7-氧代-1,6-二氮杂双环[3.2.1]辛烷-2-基]羰基]氨基]-1-哌啶羧酸叔丁酯 | tert-butyl 4-((2S,5R)-6-hydroxy-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboxamido)piperidine-1-carboxylate | 1174020-64-4 | C17H28N4O5 |
|
4-[[9-氯-7-(2-氟-6-甲氧基苯基)-5H-嘧啶并[5,4-D][2]苯并氮杂卓-2-基]氨基]-2-甲氧基苯甲酸 | alisertib | 1028486-01-2 | C27H20ClFN4O4 |
|
4-[[9-氯-7-(2,6-二氟苯基)-5H-嘧啶并[5,4-D][2]苯并氮杂卓-2-基]氨基]苯甲酸 | 4-{[9-chloro-7-(2,6-difluorophenyl)-5H-pyrimido[5,4-d][2]benzazepin-2-yl]amino}benzoic acid | 869363-13-3 | C25H15ClF2N4O2 |
|